marimastat has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 4 studies
Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (o-(chloroacetylcarbamoyl)fumagillol) | Trials (o-(chloroacetylcarbamoyl)fumagillol) | Recent Studies (post-2010) (o-(chloroacetylcarbamoyl)fumagillol) |
---|---|---|---|---|---|
215 | 28 | 53 | 476 | 10 | 31 |
Protein | Taxonomy | marimastat (IC50) | o-(chloroacetylcarbamoyl)fumagillol (IC50) |
---|---|---|---|
Methionine aminopeptidase 2 | Homo sapiens (human) | 0.593 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kuwano, M; Ono, M | 2 |
Bloys, H; Kaijzel, EL; Löwik, CW; Snoeks, TJ; van Beek, E; van Hinsbergh, VW; van Wijngaarden, J | 1 |
2 review(s) available for marimastat and o-(chloroacetylcarbamoyl)fumagillol
Article | Year |
---|---|
[Development of anti tumor agents targeting angiogenesis].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanes; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Interferon-alpha; Interleukin-12; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Platelet Factor 4; Polysaccharides, Bacterial; Sesquiterpenes; Thalidomide; Thiophenes; Triazines; Triazoles; Tumor Cells, Cultured | 1997 |
[Neovascularization and tumor development].
Topics: Angiostatins; Antibiotics, Antineoplastic; Antineoplastic Agents; Collagen; Cyclohexanes; Endostatins; Humans; Hydroxamic Acids; Interferons; Interleukin-12; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thalidomide; Thiophenes | 1998 |
2 other study(ies) available for marimastat and o-(chloroacetylcarbamoyl)fumagillol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
An in vitro model that can distinguish between effects on angiogenesis and on established vasculature: actions of TNP-470, marimastat and the tubulin-binding agent Ang-510.
Topics: Angiogenesis Inhibitors; Animals; Benzene Derivatives; Capillaries; Cyclohexanes; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hydroxamic Acids; In Vitro Techniques; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; O-(Chloroacetylcarbamoyl)fumagillol; Organophosphorus Compounds; Sesquiterpenes; Tubulin Modulators | 2010 |